Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis

被引:64
作者
Hu, Jianping [1 ]
Xu, Yong [2 ,3 ]
He, Zemin [1 ]
Zhang, Hui [1 ]
Lian, Xiaoqing [4 ]
Zhu, Tiantian [4 ]
Liang, Caihong [4 ]
Li, Jun [1 ]
机构
[1] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Huaian Peoples Hosp 2, Dept Nephrol, Huaian, Peoples R China
[3] Xuzhou Med Univ, Affiliated Huaian Hosp, Huaian, Peoples R China
[4] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Cardiovasol, Nanjing, Jiangsu, Peoples R China
关键词
cerebrovascular accident; non-alcoholic fatty liver disease; meta-analysis; INSULIN-RESISTANCE; HEPATIC STEATOSIS; UNITED-STATES; INFLAMMATION; ASSOCIATION; EPIDEMIOLOGY; OBESITY; BIAS;
D O I
10.18632/oncotarget.22755
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Recent published studies on the association between non-alcoholic fatty liver disease (NAFLD) and cerebrovascular accident (CVA) risk have yielded conflicting findings. The aim of our study was to identify the potential association by pooling all available publications. A total of nine independent studies were included into our study. The pooled odd ratio (OR) with 95% confidence interval (95% CI) was calculated to weigh the strength for the relationship between NAFLD and CVA risk. We also conducted stratified analyses by study design, ethnicity and disease classification for further elucidation. The pooled results of the present meta-analysis showed that NAFLD was related to increased risk of CVA (OR = 2.32, 95% CI 1.84-2.93, P < 0.001). Besides, NAFLD is associated with increased risk of CVA among both Caucasians (OR = 2.27, 95% CI 1.77-2.90, P < 0.001) and Asians (OR = 2.81, 95% CI 1.43-5.51, P = 0.003). Moreover, the significant association was also observed in case-control studies (OR = 2.73, 95% CI 1.67-4.48, P < 0.001) and cohort studies (OR = 2.22, 95% CI 1.71-2.89, P < 0.001), respectively. In addition, NAFLD was shown to correlate with increased risk of cerebral hemorrhage (OR = 1.85, 95% CI 1.05-3.27, P = 0.034) and the ischemic stroke (OR = 2.51, 95% CI 1.92-3.28, P < 0.001). In conclusion, our findings firstly provide strong evidence for a risk effect of NAFLD on CVA development.
引用
收藏
页码:2752 / 2760
页数:9
相关论文
共 31 条
[1]
Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events [J].
Abd El Azeem, Hamdy ;
Khalek, El-Shazly Abdul ;
El-Akabawy, Hazem ;
Naeim, Hussein ;
Khalik, Hammouda Abdul ;
Alfifi, Abdul Aziz .
JOURNAL OF THE SAUDI HEART ASSOCIATION, 2013, 25 (04) :239-246
[2]
The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA) [J].
Al Rifai, Mahmoud ;
Silverman, Michael G. ;
Nasir, Khurram ;
Budoff, Matthew J. ;
Blankstein, Ron ;
Szklo, Moyses ;
Katz, Ronit ;
Blumenthal, Roger S. ;
Blaha, Michael J. .
ATHEROSCLEROSIS, 2015, 239 (02) :629-633
[3]
Epidemiology of Non-Alcoholic Fatty Liver Disease [J].
Bellentani, Stefano ;
Scaglioni, Federica ;
Marino, Mariano ;
Bedogni, Giorgio .
DIGESTIVE DISEASES, 2010, 28 (01) :155-161
[4]
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[5]
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB [J].
Cai, DS ;
Yuan, MS ;
Frantz, DF ;
Melendez, PA ;
Hansen, L ;
Lee, J ;
Shoelson, SE .
NATURE MEDICINE, 2005, 11 (02) :183-190
[6]
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
GASTROENTEROLOGY, 2012, 142 (07) :1592-1609
[7]
THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES [J].
COCHRAN, WG .
BIOMETRIKA, 1950, 37 (3-4) :256-266
[8]
METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome [J].
Dietrich, Peter ;
Hellerbrand, Claus .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2014, 28 (04) :637-653
[10]
Cardiovascular Disease and Nonalcoholic Fatty Liver Disease Does Histologic Severity Matter? [J].
Domanski, Jeremy P. ;
Park, Stephen J. ;
Harrison, Stephen A. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (05) :427-430